AI assistant
Sending…
Cardlytics, Inc. — Director's Dealing 2019
Aug 22, 2019
33956_dirs_2019-08-22_e3492ddb-2453-4a8d-aae9-0ab2a2f64e50.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cardlytics, Inc. (CDLX)
CIK: 0001666071
Period of Report: 2019-08-22
Reporting Person: Evans David Thomas (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-08-22 | Common Stock | M | 10000 | $9.08 | Acquired | 43627 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-08-22 | Employee Stock Option (Right to Buy) | $9.08 | M | 10000 | Acquired | 2024-08-08 | Common Sock (10000.0) | Direct |
Footnotes
F1: Fully vested.
More from Cardlytics, Inc.
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Annual Report
2026
Mar 4
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 19
Regulatory Filings
2026
Jan 26